Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

144 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prospects for introducing deferiprone as potent pharmaceutical antioxidant.
Kontoghiorghes GJ. Kontoghiorghes GJ. Front Biosci (Elite Ed). 2009 Jun 1;1:161-78. Front Biosci (Elite Ed). 2009. PMID: 19482634 Review.
Deferiprone for thalassaemia.
Kontoghiorghes GJ, Agarwal MB, Grady RW, Kolnagou A, Marx JJ. Kontoghiorghes GJ, et al. Lancet. 2000 Jul 29;356(9227):428-9. doi: 10.1016/s0140-6736(05)73574-1. Lancet. 2000. PMID: 10972396 No abstract available.
Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1).
Kontoghiorghes GJ, Pattichi K, Hadjigavriel M, Kolnagou A. Kontoghiorghes GJ, et al. Transfus Sci. 2000 Dec;23(3):211-23. doi: 10.1016/s0955-3886(00)00089-8. Transfus Sci. 2000. PMID: 11099897 Review.
Effects on Mycobacterium avium replication in normal human macrophages by deferiprone (L1) and other iron chelators. Possible implications on toxicity.
Douvas GS, May MH, Kolnagou A, Kontoghiorghes GJ. Douvas GS, et al. Arzneimittelforschung. 2002;52(1):45-52. doi: 10.1055/s-0031-1299855. Arzneimittelforschung. 2002. PMID: 11838274
144 results
Jump to page
Feedback